OAT-GUT-BRAIN: Effects of Oats and Rice on Comprehensive Health of Metabolically Challenged Individuals
OAT-GUT-BRAIN: Comprehensive Health Effects of Long-term Consumption of Oats in Metabolically Challenged Volunteers - Gut-mediated Metabolomics and Vitality
1 other identifier
interventional
72
1 country
2
Brief Summary
The overall objective of this research entity is to reveal the comprehensive health impact of oats in metabolically challenged individuals in a 6-week intervention, compared to that of rice. This is achieved by investigation of the lipids, short-chain fatty acids, inflammation markers and antioxidant status from plasma, fecal microbiome, and plasma metabolome. Additionally the effect of the 6-week diet on postprandial glycemia and postprandial satiety and vitality are investigated.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2022
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 26, 2022
CompletedFirst Posted
Study publicly available on registry
September 2, 2022
CompletedStudy Start
First participant enrolled
September 12, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2027
ExpectedApril 13, 2026
March 1, 2026
1.3 years
August 26, 2022
April 7, 2026
Conditions
Outcome Measures
Primary Outcomes (2)
Changes from Baseline in Serum Total Cholesterol
Serum total cholesterol will be measured from fasting blood samples at the baseline (week 0) and after 6 week of the dietary intervention (week 6).
Week 0 and Week 6
Changes from Baseline in Interleukin-10
Interleukin-10 is measured from fasting plasma samples at the baseline (week 0) and after the 6-week diet intervention (week 6). It will be analysed as part of the Olink Target 48 Cytokine Panel (Olink Proteomics, Uppsala, Sweden) that provides absolute quantities for 45 different proteins, such as interleukins, interferons, chemokines and growth factors that are related to inflammation.
Week 0 and Week 6
Secondary Outcomes (19)
Changes from Baseline in Blood Lipids
Week 0 and Week 6
Changes from Baseline in Glucose Metabolism
Week 0 and Week 6
Changes in Postprandial Glucose metabolism
0, 15, 30, 45, 60, 90, 120, 180 minutes after the study meal at week 0 and week 6
Changes from Baseline in Inflammation markers
Week 0 and Week 6
Changes from Baseline in Plasma metabolome
Week 0 and Week 6
- +14 more secondary outcomes
Other Outcomes (7)
Changes in postprandial status of inflammation markers
0, 15, 30, 45, 60, 90, 120, 180 minutes after the study meal at week 0 and week 6
Changes postprandial status of Plasma Short-Chain Fatty Acids
0, 90, 180 minutes after the study meal at week 0 and week 6
Changes in postprandial status of Plasma metabolome
0, 15, 30, 45, 60, 90, 120, 180 minutes after the study meal at week 0 and week 6
- +4 more other outcomes
Study Arms (4)
Oat-rich and low-gluten diet with oat-rich meal test
EXPERIMENTALParticipants will consume oats as the main cereal in their diet and follow low-gluten diet for 6 weeks. In postprandial meal test, they will be served an oat-rich breakfast.
Rice-rich low-gluten diet with oat-rich meal test
ACTIVE COMPARATORParticipants will consume rice as the main cereal in their diet and follow low-gluten diet for 6 weeks. In postprandial meal test, they will be served an oat-rich breakfast.
Oat-rich low-gluten diet with rice-rich meal test
EXPERIMENTALParticipants will consume oats as the main cereal in their diet and follow low-gluten diet for 6 weeks. In postprandial meal test, they will be served a rice-rich breakfast.
Rice-rich low-gluten diet with rice-rich meal test
ACTIVE COMPARATORParticipants will consume rice as the main cereal in their diet and follow low-gluten diet for 6 weeks. In postprandial meal test, they will be served a rice-rich breakfast.
Interventions
Changes in dietary intake, metabolism, fecal microbiome, vitality and perceived health after a 6-week consumption of oat or rice-rich low-gluten diet.
Postprandial changes after the 6-week consumption of either oat or rice-rich low-gluten diet, including blood markers, microbiome, satiety, recovery and vitality.
Eligibility Criteria
You may qualify if:
- Commits to follow the instructed low-gluten diet for 6 weeks
- years of age
- BMI \> 25 kg/m\^2
- High cholesterol (without medication) characterized as total cholesterol \> 5 mmol/l, AND either LDL \> 3 mmol/l OR HDL (men/women) \< 1.0/1.2 mmol/l AND/OR Hypertension (systolic \> 140 mmHg or diastolic \> 90 mmHg).
You may not qualify if:
- Regular medication that can affect the research outcomes (balanced medication for hypertension, hypo-/hyperthyroidism, hormone replacement therapy, and inhaled medicines allowed)
- Pregnancy or lactation
- Heavy smoking
- Recent course of antibiotics (less than 3 months prior to the study)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Turkulead
- University of Eastern Finlandcollaborator
Study Sites (2)
Food Sciences, Department of Life Technologies, University of Turku
Turku, Turku, 20500, Finland
Institute of Public Health and Clinical Nutrition, University of Eastern Finland
Kuopio, 70211, Finland
Related Publications (1)
Mannila E, Nuotio P, Kuosmanen A, De Storvik S, Karlund A, Jukkara A, Tauriainen MM, Narvainen J, Kolehmainen M, Linderborg KM. Comparison of Low-Gluten Diets Rich in Oats or Rice-A 6-Week Randomized Clinical Trial With Metabolically Challenged Volunteers. Mol Nutr Food Res. 2025 Jun;69(12):e70076. doi: 10.1002/mnfr.70076. Epub 2025 May 7.
PMID: 40331457RESULT
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
August 26, 2022
First Posted
September 2, 2022
Study Start
September 12, 2022
Primary Completion
December 31, 2023
Study Completion (Estimated)
December 1, 2027
Last Updated
April 13, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, ICF, ANALYTIC CODE
- Time Frame
- IPD will be available once the primary publications are published.
- Access Criteria
- Only for collaborative research purposes with a separate agreement with the data owner, the accessibility of data and documents can be decided together.
Sensitive volunteer data may only be shared for collaborative research purposes with a separate agreement with the data owner. Metagenomic sequencing data can be found with identifier PRJEB104478 from ENA.